Aehr Test Systems to Announce Third Quarter Fiscal 2016 Financial Results on March 24, 2016
Mar 09, 2016 12:30 pm UTC| Business
FREMONT, Calif., March 09, 2016 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it will report financial results for its third quarter of fiscal...
francesca’s® Announces Reporting Date for Fourth Quarter and Fiscal Year 2015 Financial Results
Mar 09, 2016 12:30 pm UTC| Business
HOUSTON, March 09, 2016 -- Francesca’s Holdings Corporation (NASDAQ:FRAN) today announced plans to report fourth quarter and fiscal year 2015 financial results on Wednesday, March 23, 2016, before the market opens. The...
Workhorse Group Inc. Fulfills $2.975M Obligation on Its Secured Debenture to Navistar International
Mar 09, 2016 12:30 pm UTC| Business
CINCINNATI, March 09, 2016 -- Workhorse Group Inc. (NASDAQ:WKHS), a last-mile delivery technology company that is an original equipment manufacturer of medium-duty, battery-electric trucks and fully integrated unmanned...
Mar 09, 2016 12:17 pm UTC| Business
Dublin, March 09, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/8zrhgq/additive) has announced the addition of the "Additive Manufacturing in Space and Defense Aerospace Markets" ...
Global Fleet Management Report 2015-2016 - Trends, Technologies & Forecasts
Mar 09, 2016 12:07 pm UTC| Business
Dublin, March 09, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/n5rtcn/fleet_management) has announced the addition of the "Fleet Management - World 2015/2016" report to their...
Mar 09, 2016 12:05 pm UTC| Business
PRINCETON, N.J., March 09, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, and SGI-DNA, a wholly owned subsidiary of Synthetic Genomics, Inc. (SGI), today...
Onconova Announces Publication of Rigosertib Phase 3 ONTIME Data in Lancet Oncology
Mar 09, 2016 12:01 pm UTC| Business
-- Online-First Publication Currently Available -- -- First Randomized Trial With Survival Endpoint in Second-Line Myelodysplastic Syndromes (MDS) -- -- New Phase 3 “INSPIRE” Study of IV Rigosertib Currently Enrolling...